The largest database of trusted experimental protocols

3 protocols using cd20 bv421

1

Multicolor Cytometry for Treg and MDSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Treg cells, isolated PBMCs were stained with anti-CD4-FITC (RPA-T4/555346), CD25-APC (M-A251/555434), and CD45RA-PerCP-Cy 5.5 (HI100/563429) antibodies (BD Biosciences, San Jose, CA, USA) for 45 min, and antibody stained samples were washed twice. After intracellular staining, Treg cell frequencies were analyzed by a BD FACSVerse (BD Biosciences) flow cytometer. For MDSCs, isolated PBMCs were stained with anti-CD3-BV421 (UCHT1/562426), CD19-BV421 (HIB19/562440), CD56-BV421 (NCAM16.2/562751), CD20-BV421 (2H7/562873), CD11b-BB515 (ICRF44/564517), CD15-PerCP-Cy 5.5 (HI98/560828), CD14-APC (M5E2/555399), and HLA-DR-PE (G46-6/555812) antibodies (BD Biosciences) for 45 min, washed twice, and analyzed by a BD FACSVerse (BD Biosciences) flow cytometer. For 7-AAD and propidium iodide staining, isolated PBMCs were stained with 7-AAD (Biolegend, San Diego, CA, USA) or PI (BD Biosciences) for 10 min and then analyzed on a BD FACSVerse (BD Biosciences). Gating strategies are shown in Supplementary Fig. S1. PBMC viability before MDSC analysis is shown in Supplementary Fig. S2.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
For MDSCs, isolated PBMCs were stained with anti‐CD3‐BV421 (UCHT1/562426), CD19‐BV421 (HIB19/562440), CD56‐BV421 (NCAM16.2/562751), CD20‐BV421 (2H7/562873), CD11b‐BB515 (ICRF44/564517), CD15‐PerCP‐Cy 5.5 (HI98/560828), CD14‐APC (M5E2/555399), and HLA‐DR‐PE (G46‐6/555812) antibodies (BD Biosciences, San Jose, CA, USA) for 45 min. For lectin‐type oxidized LDL receptor 1 (Lox‐1) expression on PMN‐MDSCs, lox‐1‐BV421 (15C4/358610) (Biolegend, San Diego, CA, USA) was used. For Treg cells, isolated PBMCs were stained with anti‐CD4‐FITC (RPA‐T4/555346), CD25‐APC (M‐A251/555434), CD45RA‐PerCP‐Cy 5.5 (HI100/563429), and Foxp3‐PE (259D/C7/560046) antibodies (BD Biosciences) for 45 min. For CD8+ T cells, isolated PBMCs were stained with anti‐CD8‐APC (RPA‐T8/555369) (BD Biosciences), CD39‐PE‐Cy7 (A1/328212) (Biolegend), and PD‐1‐PerCP‐Cy5.5 (EH12.1 /561273) (BD Biosciences) antibodies. Samples were washed twice and then read on a BD FACSVerse (BD Biosciences) flow cytometer. Dead cells were excluded using 7‐Amino‐Actinomycin D (7AAD) (Biolegend). Gating strategies for PMN‐MDSCs, M‐MDSCs, and CD8+ T cells are shown in Supporting information Fig. 1A‐C. All the process of T‐cell assays and flow cytometry analysis (linear axis) adhered to the guidelines of MIATA compliant and Cossarizza [30].
+ Open protocol
+ Expand
3

Phenotyping of Rhesus Macaque PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen PBMCs were thawed, and cell viability was consistently >90%. After the incubation with the FcR blocking (BD) and Aqua Dead Cell Stain (Molecular Probes), as described in Section “Flow Cytometry of BM PCs,” the cells were washed with FACS buffer and surface-stained for 15 min at 4°C with antibodies against CD3 BV786 (BD), CD20 BV421 (BD), CD138 PE (eBioscience), CD80 clone L307.4 APC-H7 (BD), HLA-DR clone L243 PerCP-Cy5.5 (BD), CD14 clone M5E2 BV786 (BD), CD16 clone 3G8 BV786 (BD), CD98 FITC (eBioscience), and CD49d APC (BD) or CD31 Alexa 647 (BD). Cells were washed twice with FACS buffer and incubated in 100 μl of Cytofix/Cytoperm (BD) for 20 min at 4°C. Cells were then washed twice in Perm/Wash buffer (BD) and intracellularly stained in 100 μl of Perm/Wash buffer for 15 min at 4°C with IgG clone G18-145 PE-Cy7 (BD), followed by two washes in Perm/Wash buffer and two in FACS buffer. All Abs were previously titrated for optimal staining of rhesus macaque PBMCs. Samples were collected on a FACS LSRII (BD Immunocytometry Systems) and analyzed using FlowJo software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!